Hepatocyte buds derived from progenitor cells repopulate regions of parenchymal extinction in human cirrhosis
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Repair of cirrhotic livers occurs, in part, by repopulation with hepatocytes through the stem/progenitor pathway. There remain many uncertainties regarding this pathway. Hepatocyte “buds” occurring in broad septa are hypothesized to be the anatomic manifestation of this pathway. Our purpose was to define a morphologic sequence of bud maturation to allow a quantitative measure of the importance of the stem/progenitor pathway in humans. Histologic sections from 37 liver resection specimens were stained with trichrome, epithelial cell adhesion molecule (EpCAM), K19, CD34, glutamine synthetase (GS), and Ki‐67. Specimens were stratified by etiology (10 biliary, 22 nonbiliary, five controls) and stage. Buds were defined as clusters of hepatocytes within septa. Five levels of bud maturation (0‐4) were defined by the progressive increase in hepatocyte progeny relative to cholangiocytes. Level 0 single‐cell buds are K19 + /GS + /EpCAM + /Heppar1 − . In level 1, the progeny are morphologically hepatocytes (K19 − /GS + /EpCAM + /Heppar1 + ). In level 2‐4 buds, hepatocytes increase and become progressively GS − and EpCAM − . Associated endothelium is CD34 + in level 1‐2 buds and becomes CD34 − near hepatic veins in level 3‐4 buds. Progeny of the bud sequence may represent up to 70% of hepatocytes (immaturity index of 70%). In biliary disease, bud number is reduced in association with duct loss and cholestatic destruction of nascent buds. Conclusions : The stem/progenitor pathway, manifested anatomically by the bud sequence, is a major mechanism for repopulation of cirrhotic livers. The bud sequence reveals some critical features of hepatic morphogenesis, including that 1) the majority of distal cholangiocytes have stem‐like properties, and 2) availability of bile ducts and/or venous drainage are limiting factors for regeneration. (H epatology 2015;61:1696–1707)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fausto, N., Campbell, J. S., & Riehle, K. J. (2006) · Hepatology · doi:10.1002/hep.20969 · Cited by 1,378
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry
Bioulac-Sage, P., Rebouissou, S., Thomas, C., Blanc, J.-F., Saric, J., Sa Cunha, A., Rullier, A., Cubel, G., Couchy, G., Imbeaud, S., et al. (2007) · Hepatology · doi:10.1002/hep.21743 · Cited by 590
Richardson, M. M., Jonsson, J. R., Powell, E. E., Brunt, E. M., Neuschwander–Tetri, B. A., Bhathal, P. S., Dixon, J. B., Weltman, M. D., Tilg, H., Moschen, A. R., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.012 · Cited by 482 · cited 1×
“However, we have seen progenitor activity and buds in periportal regions of early-stage disease as well as in broad septa of late-stage disease, as noted also by others.(25,26) In addition, our data did not show a significant change in the hepatocellular proliferative index between early and late disease.”
BackgroundD'Ambrosio, R., Aghemo, A., Rumi, M. G., Ronchi, G., Donato, M. F., Paradis, V., Colombo, M., & Bedossa, P. (2012) · Hepatology · doi:10.1002/hep.25606 · Cited by 409 · cited 1×
“GS expression is also a non-specific marker seen in response to hepatocellular injury (18, 21) and in neoplastic hepatocytes with beta-catenin mutation (22).”
BackgroundLiver Progenitor Cells Yield Functional Hepatocytes in Response to Chronic Liver Injury in Mice
Español–Suñer, R., Carpentier, R., Van Hul, N., Legry, V., Achouri, Y., Cordi, S., Jacquemin, P., Lemaigre, F., & Leclercq, I. A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.024 · Cited by 356
The biliary epithelium gives rise to liver progenitor cells
Rodrigo-Torres, D., Affò, S., Coll, M., Morales-Ibanez, O., Millán, C., Blaya, D., Alvarez-Guaita, A., Rentero, C., José Lozano, J., Maestro, M. A., et al. (2014) · Hepatology · doi:10.1002/hep.27078 · Cited by 189 · cited 1×
“45% of hepatocytes.(11,12) This contrasts with data in human cirrhosis,(10) where more than half of the hepatocytes often had features of stem-cell derivation.”
ResultYoon, S.-M., Gerasimidou, D., Kuwahara, R., Hytiroglou, P., Yoo, J. E., Park, Y. N., & Theise, N. D. (2011) · Hepatology · doi:10.1002/hep.24122 · Cited by 177 · cited 8×
“Another source is a population of cells with stem-like properties located in small bile ducts and canals of Hering (7-10).”
BackgroundResultInfluentialSasaki, M., Ikeda, H., Yamaguchi, J., Nakada, S., & Nakanuma, Y. (2008) · Hepatology · doi:10.1002/hep.22348 · Cited by 125 · cited 1×
“On the other hand, our data support a role for senescence of cholangiocytes in chronic liver disease, as suggested by others.(30,31) That is, the increase in number of simple duct profiles in stage 4C cirrhosis may represent a failure of these ducts to participate in bud formation and attendant hepatocellular generati…”
ResultReview article: the reversibility of cirrhosis
Sohrabpour, A. A., Mohamadnejad, M., & Malekzadeh, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12044 · Cited by 80
Cited by
Liver regeneration: biological and pathological mechanisms and implications
Michalopoulos, G. K., & Bhushan, B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0342-4 · Cited by 998
Ductular reaction in liver diseases: pathological mechanisms and translational significances
Sato, K., Marzioni, M., Meng, F., Francis, H., Glaser, S., & Alpini, G. (2019) · Hepatology · doi:10.1002/hep.30150 · Cited by 423
“In addition, the expression level of markers in these transitional cells varies depending on the maturation of liver formation.(24,25) It is not fully elucidated to date whether cholangiocytes and/or HPCs can transdifferentiate into hepatocytes during liver regeneration.”
BackgroundLiver regeneration — mechanisms and models to clinical application
Forbes, S. J., & Newsome, P. N. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.97 · Cited by 411
Understanding Liver Regeneration
Gilgenkrantz, H., & Collin de l'Hortet, A. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.03.008 · Cited by 171
Acquisition of epithelial plasticity in human chronic liver disease
Gribben, C., Galanakis, V., Calderwood, A., Williams, E. C., Chazarra-Gil, R., Larraz, M., Frau, C., Puengel, T., Guillot, A., Rouhani, F. J., et al. (2024) · Nature · doi:10.1038/s41586-024-07465-2 · Cited by 142
“Notably, cell-type-specific clusters mostly overlap independently of the disease stage, except for hepatocytes, which display clear transcriptional changes following disease progression, even after a batch correction of technical effects using Harmony 40 (Fig.”
Metadata
- Authors
- Stueck, A. E., & Wanless, I. R.
- Venue
- Hepatology
- Published
- 2015-03-18
- Volume
- 61
- Issue
- 5
- Pages
- 1696-1707
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W1828914257
- Cited by
- 109
- References
- 9
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatocyte buds derived from progenitor cells repopulate regions of parenchymal extinction in human cirrhosis. https://app.cochat.ai/papers/10.1002/hep.27706
- The paper
- Stueck, A. E., & Wanless, I. R. (2015). Hepatocyte buds derived from progenitor cells repopulate regions of parenchymal extinction in human cirrhosis. Hepatology. https://doi.org/10.1002/hep.27706
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.